High-dose BEAM chemotherapy with autologous peripheral blood progenitor-cell transplantation for unselected patients with primary refractory or relapsed Hodgkin's disease.

Source:http://linkedlifedata.com/resource/pubmed/id/10942053

Download in:

View as

General Info

PMID
10942053